Given Imaging GIVN
-
Given Imaging Falls Slightly Short in the First Quarter, but Not Enough to Reduce Our Fair Value
Given Imaging GIVN presented first-quarter results that fell slightly short of our expectations, but not enough to move the needle on our fair …
-
Given Imaging ( GIVN ): Q1 EPS of $0.06 misses by $0.06. Revenue of $41.8M (+4.6% Y/Y). (PR)
Given Imaging ( GIVN ): Q1 EPS of $0.06 misses by $0.06 . Revenue of $41.8M (+4.6% Y/Y). ( PR ) Post your comment!
-
Ramesh Gulati Interview: 11 Healthcare Names Poised For Gains
By Kate Stalter : The healthcare sector has lots of room to grow because of increasing demand from aging baby boomers, among other factors, says advisor Ramesh Gulati . He tells MoneyShow.com about some smaller stocks that are not household names. Kate Stalter : I'm speaking with Ramesh Gulati of
-
A Med-Tech Shopping List For Japanese Companies
By Stephen Simpson : Outside of pharmaceuticals and "big iron" applications like imaging, Japanese companies haven't made much impression on the U.S. healthcare market. That may be changing, though. As Japan faces its own aging population and companies look to diversify from traditional industries,
-
Exact Sciences Could Be Exactly What Biotech Investors Need
By Stephen Simpson : Genomic testing has been a mixed blessing for investors thus far. While progress in the lab and clinic has been significant, the investment picture has followed a pretty familiar pattern - huge enthusiasm (and overvaluation) up front, crushing disappointment, and then general
-
Given Imaging Pushes Ahead with Pivotal Trials for PillCam COLON
Given Imaging GIVN provided a strong finish to 2011 with its solid fourth-quarter performance. While the firm slightly exceeded our expectations …
-
New Morningstar Analyst Report - Given Imaging
… disclosure on executive performance metrics.Based in Israel, Given Imaging develops, manufactures, and markets patient-friendly ..... impressive enough to garner FDA approval of the product. Given Imaging has pioneered an entirely new way to diagnose various gastrointestinal …
-
Given Imaging ( GIVN ): Q4 EPS of $0.25 beats by $0.06. Revenue of $48.5M (+8% Y/Y) beats by $1.7M. Shares +11.9% AH. (PR)
Given Imaging ( GIVN ): Q4 EPS of $0.25 beats by $0.06 . Revenue of $48.5M (+8% Y/Y) beats by $1.7M . Shares +11.9% AH. ( PR ) Post your comment!
-
UPDATE 1- Given Imaging files lawsuit in Seoul against Intromedic
Nov 30 (Reuters) - Given Imaging Ltd said it has filed a lawsuit against South Korea's Intromedic Co Ltd, alleging infringement of two patents related to its capsule endoscopy system.
-
Given Imaging ([[ GIVN ]] +1.2%) gets a boost after announcing the initiation of trials in Japan using its colorectal imaging technology, PillCam Colon 2. The study part of the company's plan to ...
Given Imaging ( GIVN +1.2% ) gets a boost after announcing the initiation of trials in Japan using its colorectal imaging technology, PillCam Colon …